UNITED ~~STATES SECURITIES~~STATESSECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of January ~~October 2007~~2008

Commission File No. 0-29328

ADVANCED PROTEOME THERAPEUTICS ~~CORPORATION~~ CORPORATION(Translation of registrant's name into English)

BioSquare, 650 Albany Street, Boston, MA ~~02118~~ 02118(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F [X] Form 40-F [ ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) [ ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7) [ ]

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes [ ] No [X]

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A

SUBMITTED HEREWITH

Exhibits 99.1 News Release Dated January 21, 2008 - APC Grants Stock Options

99.1	Audited Annual Financial Statements for the Fiscal Year ended July 31, 2007
99.2	Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Fiscal Year Ended July 31, 2007
99.3	Certification of Chief Executive Officer
99.4	Certification of Chief Financial Officer

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ADVANCED PROTEOME THERAPEUTICS CORPORATION

Date: ~~December 3~~Jan 21, ~~2007~~2008

/s/ Alexander (Allen) ~~Krantz________________ Name~~Krantz________________Name: Alexander (Allen) Krantz Title: President and Chief Executive Officer

Filing Compare · Advanced Proteome Therapeutics CORP